4.7 Letter

Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human Plasma

Journal

HYPERTENSION
Volume 77, Issue 3, Pages E29-E31

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.120.16724

Keywords

coronavirus; heart failure; kidney diseases; pandemics; renin-angiotensin system

Funding

  1. National Institutes of Health [HD-084227, HL-146818, HL-148394, HL-148910]
  2. American Heart Association [GRNT20480121, TPA34170522]
  3. Groskert Heart Fund
  4. Wake Forest Venture Fund
  5. Farley-Hudson Foundation (Jacksonville, NC)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available